SOHM Inc (SHMN)

[Trademanager]

From Q2 Sales and Marketing strategy:

https://backend.otcmarkets.com/otcapi/company/financial-report/205818/content

SOHM management announce gross revenue of $287.371 for 1st and 2nd qtrs., company's combined gross revenue is approx. 65% more than last fiscal year’s total revenue. We are pleased with results & very confident in our operation and developments.

Company Tweets: https://twitter.com/sohminc

SOHM focuses on fast growing, underserved emerging markets in the Far East, Africa, newly added European
Union states and Latin America. Despite the challenges of the current economic climate, much of the
world’s population has a great need for basic pharmaceuticals, but these drugs are either too expensive or
not available to vast populations in these regions. The Company recently expanded its generic drug
distribution to address emerging pharmaceutical markets in Indonesia, Thailand, the Philippines, and
Malaysia.

SOHM's strategic manufacturing facility is licensed by the FDA. The license indicates
compliance with Current Good Manufacturing Practice (CGMP) Regulations: Division of Manufacturing
and Product Quality and World Health Organization (WHO) regulations.